K Vaidy et al. JPGN Reports 2020; Full text: Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease

This in-depth report reviews pyoderma gangrenosum including the differential diagnosis, the pathophysiology/genetics, presentation/diagnosis and treatment approaches. Anti-TNF therapy: “Currently available published data support using an anti-TNF-α biologic agent as first-line therapy for severe PG therapy in pediatric IBD, as well as for those cases that have not responded to local therapies.”

Related blog posts -PG:

• IBD and Immune-Mediated Diseases
• Tofacitinib Case Reports for Acute Severe UC and Pyoderma Gangrenosum
• Pyoderma Gangrenosum in Ulcerative Colitis
• Image Only: Pyoderma Gangrenosum
• February Briefs